Simultaneous determination of diltiazem and quinidine in human plasma by liquid chromatography.

[1]  P. Yeung,et al.  Stability of Diltiazem and Its Metabolites in Plasma During Storage , 1991, Therapeutic drug monitoring.

[2]  D. Roden,et al.  Quinidine reduces clearance of (+)‐propranolol more than (−)‐propranolol through marked reduction in 4‐hydroxylation , 1990, Clinical pharmacology and therapeutics.

[3]  K. Goa,et al.  Diltiazem. A reappraisal of its pharmacological properties and therapeutic use. , 1990, Drugs.

[4]  T. Montague,et al.  High-performance liquid chromatographic assay of diltiazem and six of its metabolites in plasma: application to a pharmacokinetic study in healthy volunteers. , 1989, Journal of pharmaceutical sciences.

[5]  L. Dubé,et al.  Stability study of diltiazem and two of its metabolites using a high performance liquid chromatographic method. , 1989, Biopharmaceutics & drug disposition.

[6]  H. Imai,et al.  Isolation of new quinidine metabolites and simultaneous determination of quinidine and its metabolites in blood and urine by direct injection HPLC analysis , 1985 .

[7]  C. M. Smith,et al.  Comparison of quinidine by fluorescence polarization immunoassay and high pressure liquid chromatography. , 1984, Journal of analytical toxicology.

[8]  N. Holford,et al.  Improved liquid-chromatographic assay of quinidine and its metabolites in biological fluids. , 1982, Clinical chemistry.

[9]  B. Finkle,et al.  An HPLC method for the quantitation of quinidine and its metabolites in plasma: an application to a quinidine-phenytoin drug interaction study. , 1982, Journal of analytical toxicology.

[10]  Reidenberg Mm,et al.  Specific determination of quinidine and (3S)-3-hydroxyquinidine in human serum by high-pressure liquid chromatography. , 1977 .

[11]  D. Aviado,et al.  Drug Action, Reaction, and Interaction. I. Quinidine for Cardiac Arrhythmias , 1975, Journal of clinical pharmacology.